Quadria Capital
Singapore, Central Singaporequadriacapital.com
Overview
Quadria Capital is an Asia healthcare-focused private equity firm that aims to maximize returns by investing in the high-growth healthcare sector of some of the world's fastest-growing economies in South Asia and Southeast Asia, including Healthcare Delivery, Life Sciences, Medical Technology, and Associated Healthcare Services subsectors. The firm aims to create significant and sustainable shareholder value by supporting strong, professionally run, stable, and scalable healthcare organizations to address the critical and undersupplied healthcare needs in Asia.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nobel Hygiene | May 2025 | Growth Equity | Co-investor |
| Aragen Life Sciences | Jan 2025 | Private Equity | Lead |
| NephroPlus | May 2024 | Series F | Lead |
| MediBuddy | Aug 2023 | Early Funding | Co-investor |
| Maxivision Eye Hospital | Jul 2023 | Private Equity | Lead |
Key People
Gerald Ng
Managing Director, Investor Relations
Wilder Fulford
Operating Partner
Ewan Davis
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
